The Harrington Group Advisory Board charter has the Advisory Board meeting approximately six monthly to provide scientific advice and guidance to the Company to assist with its strategic decision making. The Advisors also work closely with each other in between the Advisory Board meetings and some provide additional consulting services to the Company.
Board of Advisors
Colonel John B. Alexander, Ph.D. (US Army Ret) - Chairman
Colonel Alexander is recognized and acknowledged as one of the world's leading authorities on non-lethal weapons and is credited with developing the modern concept of non-lethal defense. He currently serves as a consultant to the US Joint Special Operations University and is a member of the National Research Council Committee for Assessment of Non-Lethal Weapons Science and Technology in the US.
Colonel Alexander continues to consult to the US government and provide guidance in military situations globally in which role he recently served as a mentor to the senior leadership of the Afghan MOD in Kabul. He previously headed the Los Alamos Laboratory program on non-lethal weapons. He has served as the US representative on four international studies conducted by NATO and has chaired most of the major conferences on non-lethal weapons over the past decade.
His books include "Future War" (foreword by Tom Clancy) which is "the bible for those seeking answers to the role of non-lethal weapons in modern warfare" according to General E.C. Meyers, former Chief of Staff, US Army. Numerous articles by Colonel Alexander have been published and he has also appeared on many television programs including: Dateline, Fox News, Larry King, CNN in the US as well as programs in Australia, Denmark, France, Germany, Italy, Switzerland, Netherlands, the UK, and Japan.
As a member of the Council on Foreign Relations non-lethal warfare study, he was instrumental in the report that is credited with causing the Department of Defense to create a formal Non-Lethal Weapons Policy in July 1996. He has also conducted numerous non-lethal warfare briefings to the highest levels of government including the White House Staff, National Security Council, Members of Congress, Director of Central Intelligence, and senior Defense officials.
Christopher C. Green, MD, PhD, FAAFS
Dr Green is in the practice of forensic medicine (American Academy of Forensic Sciences) and neuroimaging (Detroit Medical Center/Harper University Hospital/Wayne School of Medicine). His work clinically relates to his expertise as a neurophysiologist with a specialty in electrophysiology. A special research interest involves the way cognition in "making decisions under stress" are modulated by brain systems and neuromuscular control. He is both a faculty member at the Medical School and Fellow in Diagnostic Radiology, and Executive Director for Emergent Technologies.
Dr Green serves on numerous Department of Defense, Intelligence and National Academy of Sciences Commissions. He Chairs the Science Board for the Undersecretary of the Army for Operations Research and has served as Chair of the Board on Army Science and Technology. He holds the National Intelligence Medal for investigations in forensic intelligence and served as an Officer and continues as a consultant with the Central Intelligence Agency.
Edward L. Stephen, DVM
Dr Edward L. Stephen is a specialist in bioterrorism and biodefense and in this field also heads up the biodefense division of MDM Group, Inc.
His initial working assignment was at Ft. Detrick where, in the Special Operations Division, he played key roles in bioterrorism defense including assessment of vulnerability of limited targets such as the New York subway system and the Pentagon. Further, he was involved in the R&D of a range of weapons and helped to test and evaluate various kinds of drugs, chemicals, and toxins as they might relate to capture or restraint.
Most recently and for the past five (5) years, Dr. Stephen has been a Senior Project Manager at the International Science and Technology Center (ISTC; www.istc.ru). In this role, he has been evaluating the scientific experience and expertise of scientists and support personnel involved in the R&D of biological weapons of mass destruction (BioWMD). He has reviewed the credentials and publications of scientists and support personnel of literally thousands of individuals as the initial step of integrating this experience and expertise into collaborative bio-defense research projects between the governments of Russia and the US. During future visits to Russia, he will be discussing the current and future R&D needs of the Harrington Group with various organisations.
Allen I Bain, PhD
Dr Bain is a pharmacologist focused on new drug development including, treatments for disorders of the brain, heart and other electrically active tissue. As a co-founder, officer, or director of several companies spanning nearly two decades, Dr Bain has participated in leadership roles in both the business and the science of drug discovery. Most notably, Dr. Bain co-founded Cardiome Pharma (NASDAQ: CRME), whose flagship ion channel modulating drug to treat cardiac arrhythmias is in Phase 3 clinical trials in the U.S., supported by a large pharmaceutical company. Until recently, Dr Bain was an honorary lecturer at the Department of Pharmacology and Therapeutics at the University of British Columbia, where he was awarded his doctorate in pharmacology in 1994 for his work in neuroscience.